Home › NDC Lookup › RxCUI directory › RxCUI 2705739

Insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] — RxCUI 2705739

Name: Insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] (RxCUI 2705739)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2705739 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2705739

Official nameInsulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asMerilog 100 UNT/ML Injectable Solution

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Insulin Aspart (rDNA Origin) Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Insulin aspart is a man-made, rapid-acting insulin that is very similar to the insulin your body makes naturally, but it works faster. After you inject it under the skin, it starts...
What exactly is insulin aspart and how is it different from regular insulin?
Generally, you should inject it within about 5 to 10 minutes before a meal so it starts working as your blood sugar begins to rise from food. The exact timing depends on which prod...
When should I inject insulin aspart — before or after eating?

📖 Read our full Insulin Aspart (rDNA Origin) Injection guide →

🕸️ Concept Web — How Insulin aspart-szjj 100 UNT/ML Injectable Soluti... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Insulin aspart-szjj 100 UNT/ML Injectable Solution [Merilog] RxCUI 2705739 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Insulin aspart, human 51428 IN
- Insulin aspart-szjj 2705729 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Merilog 2705734 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Insulin aspart, human Injectable Solution 378914 SCDF
- Insulin aspart-szjj Injectable Solution 2705732 SCDFP
- Insulin aspart, human Injectable Product 1157463 SCDG
- Insulin aspart-szjj Injectable Product 2705731 SCDGP
- Insulin aspart, human Injectable Solution [Merilog] 2705737 SBDF
- Insulin aspart-szjj Injectable Solution [Merilog] 2705738 SBDFP
- Merilog Injectable Product 2705736 SBDG
- Injectable Solution 316949 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Insulin aspart-szjj 100 UNT/ML Injectable Solution 2705733 SCD
- Insulin aspart-szjj 100 UNT/ML 2705730 SCDC
- Insulin aspart-szjj 100 UNT/ML [Merilog] 2705735 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Insulin aspart-szjj 100 UNT/ML Injectable Solution SCD · 2705733
Insulin aspart-szjj 100 UNT/ML SCDC · 2705730
Insulin aspart, human Injectable Solution SCDF · 378914
Insulin aspart-szjj Injectable Solution SCDFP · 2705732
Insulin aspart, human Injectable Product SCDG · 1157463
Insulin aspart-szjj Injectable Product SCDGP · 2705731

Brand-Name Concepts

Insulin aspart-szjj 100 UNT/ML [Merilog] SBDC · 2705735
Insulin aspart, human Injectable Solution [Merilog] SBDF · 2705737
Insulin aspart-szjj Injectable Solution [Merilog] SBDFP · 2705738
Merilog Injectable Product SBDG · 2705736
Merilog BN · 2705734

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 2705739 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00024-5927-00	1 VIAL, GLASS in 1 CARTON (0024-5927-00) / 10 mL in 1 VIAL,...	MERILOG	Sanofi-Aventis U.S. LLC	2025-02-14
00024-5928-05	5 SYRINGE in 1 BOX (0024-5928-05) / 3 mL in 1 SYRINGE (0024...	MERILOG	Sanofi-Aventis U.S. LLC	2025-02-14

Observed labelers: Sanofi-Aventis U.S. LLC (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ml · median

$7.7453

Range $6.7727–$8.7179 · middle 50% $7.2590–$8.2316 · 2 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.